Advertisement
Global Market Insights

OpenAI’s No. 2 Executive Fidji Simo Steps Down After Medical Leave

July 11, 2026
09:12 AM
3 min read

Key Points

Fidji Simo, OpenAI's No. 2 executive, steps down to part-time role after three-month medical leave.

POTS is a chronic neuroimmune condition causing heart palpitations, fatigue, and fainting when standing.

Her responsibilities split between Greg Brockman, Sarah Friar, and Jason Kwon with no successor named.

Departure marks latest executive turnover as OpenAI prepares for potential 2027 IPO.

Be the first to rate this article

OpenAI’s second-ranking executive, Fidji Simo, announced on July 9 she is stepping down from her full-time role as CEO of AGI deployment to become a part-time adviser. The move follows three months of medical leave after a severe flare-up of postural orthostatic tachycardia syndrome, a chronic neuroimmune condition she has lived with for seven years. Her responsibilities will be split among OpenAI President Greg Brockman, CFO Sarah Friar, and Chief Strategy Officer Jason Kwon.

Advertisement

Why Simo is stepping back now

Simo took medical leave in April after a severe exacerbation of POTS worsened. She said in an X post that three months away made clear her recovery would take far longer and be more complex than expected. The 40-year-old executive, who joined OpenAI in mid-2025 as CEO of Applications, said she needed to focus fully on recovery rather than day-to-day management. Sam Altman, OpenAI’s CEO, said he was grateful for her work and friendship.

What POTS is and why it matters

POTS is a neuroimmune condition affecting the autonomic nervous system, which regulates involuntary functions like heart rate. Symptoms include chronic fatigue, heart palpitations, dizziness, sweating, nausea, fainting, and headaches, triggered when a person stands from a seated position. Simo was diagnosed in 2019 and has managed the condition for seven years while building her career at Meta and Instacart.

The leadership gap during IPO prep

Simo’s departure marks the latest executive turnover at OpenAI as the company prepares for a potential 2027 IPO. Bloomberg reported that her product and business responsibilities will be split between Brockman, Friar, and Kwon, according to an internal memo. No named successor or succession plan has been disclosed. OpenAI also unveiled a new super-app on July 9 designed to help white-collar workers access coding tools without high costs.

Simo’s path and the advice she didn’t take

Simo revealed that Mark Zuckerberg advised her to take a full year of medical leave while she was at Meta, but she declined. She wrote that her drive to seize opportunities, which took her from a small town in southern France to Silicon Valley by age 40, also made stepping back extraordinarily difficult. She now acknowledges that grit alone is not enough and that caring for health enables longer-term impact.

Advertisement

Final Thoughts

Simo’s transition from full-time executive to part-time adviser reflects a broader pattern of executive changes at OpenAI ahead of its IPO. Her departure leaves a leadership gap in AGI deployment and applications, with no successor named. The split of her duties among three executives signals potential restructuring as the company scales.

FAQs

Why did Fidji Simo leave OpenAI?

Simo stepped down after three months of medical leave for POTS, a chronic neuroimmune condition. She said recovery would take longer and be more complex than expected, requiring her full focus.

What is POTS and how does it affect people?

POTS is a neuroimmune condition affecting heart rate regulation. Symptoms include chronic fatigue, heart palpitations, dizziness, fainting, and nausea, triggered when standing from a seated position.

Who is taking over Fidji Simo’s responsibilities at OpenAI?

Her duties are being split among Greg Brockman, Sarah Friar, and Jason Kwon, according to Bloomberg’s report of an internal memo.

When did Fidji Simo join OpenAI?

Simo joined OpenAI in mid-2025 as CEO of Applications, later promoted to CEO of AGI deployment earlier in 2026.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.

About Author

Author

Danny Kontos

Co Founder

Danny Kontos has been a stock investor since 2007 and co-founded Meyka in 2023. He keeps a small, focused portfolio and only moves when the numbers are hard to argue with. He has waited years on a single position before. Before Meyka, he ran a web hosting company and a mortgage lending platform, so he knows what a well-run business actually looks like under the hood. This article did not come from a news cycle. It came from someone who has been watching this space for a long time.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)